KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Long-Term Deferred Tax (2018 - 2026)

Takeda Pharmaceutical has reported Long-Term Deferred Tax over the past 9 years, most recently at $3.1 billion for Q1 2026.

  • For Q1 2026, Long-Term Deferred Tax rose 28.02% year-over-year to $3.1 billion; the TTM value through Mar 2026 reached $3.1 billion, up 28.02%, while the annual FY2026 figure was $3.2 billion, 33.16% up from the prior year.
  • Long-Term Deferred Tax was $3.1 billion for Q1 2026 at Takeda Pharmaceutical, up from $2.4 billion in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $3.1 billion in Q1 2022 and bottomed at $2.4 billion in Q1 2025.
  • The 5-year median for Long-Term Deferred Tax is $2.8 billion (2023), against an average of $2.8 billion.
  • Year-over-year, Long-Term Deferred Tax dropped 11.3% in 2023 and then rose 28.02% in 2026.
  • Over 5 years, Long-Term Deferred Tax stood at $3.1 billion in 2022, then dropped by 11.3% to $2.8 billion in 2023, then dropped by 3.95% to $2.7 billion in 2024, then dropped by 8.57% to $2.4 billion in 2025, then increased by 28.02% to $3.1 billion in 2026.
  • The last three reported values for Long-Term Deferred Tax were $3.1 billion (Q1 2026), $2.4 billion (Q1 2025), and $2.7 billion (Q1 2024) per Business Quant data.